Anti-coronavirus antibodies and methods of use

US11447541B1 · kind B1 · utility

Assignees

• AbCellera Biologies Inc. · CA
• The United States of America, as represented by the Secretary, Department of Health and Human Svcs. · US

Inventors

• Kathryn WESTENDORF · Vancouver, CA
• Stefanie Zentelis · Vancouver, CA
• Krithika Muthuraman · Toronto, CA
• Kevin JEPSON · Vancouver, CA
• Ester FALCONER · Vancouver, CA
• John Mascola · Rockville, US
• Barney Graham · Rockville, US
• Kizzmekia Corbett · Wheaton, US
• Julie Ledgerwood · Bethesda, US
• Lingshu Wang · North Potomac, US
• Olubukola Abiona · Bethesda, US
• Wei Shi · 安丰镇, CN
• Wing-Pui Kong · Germantown, US
• Yi Zhang · Edison, US
• Bryan Edward Jones · Carmel, US
• Denisa FOSTER · San Diego, US
• Julian Davies · Village of La Jolla, US
• Qing Chai · San Diego, US
• Christopher Carl Frye · Bargersville, US
• Ganapathy Gopalrathnam · Fishers, US
• Jörg HENDLE · San Diego, US
• John Michael SAUDER · Carlsbad, US
• Jeffrey Streetman Boyles · Indianapolis, US
• Anna PUSTILNIK · San Diego, US

Key dates

• Filing date: Jun 22, 2021
• Grant date: Sep 20, 2022
• Expiry date: Jun 22, 2041

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/26
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Antibodies that bind SARS-CoV Spike protein, SARS-CoV-2 Spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.